Adze1.C
/ Adze Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 26, 2025
A Study to Evaluate Adze1.C in Participants With Metastatic Melanoma
(clinicaltrials.gov)
- P1 | N=30 | Not yet recruiting | Sponsor: Adze Biotechnology Australia Pty Ltd
New P1 trial • Melanoma • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1